Sensata Technologies (NYSE:ST – Get Free Report) issued an update on its fourth quarter earnings guidance on Monday morning. The company provided EPS guidance of $0.71-0.76 for the period, compared to the consensus EPS estimate of $0.85. The company issued revenue guidance of $870-900 million, compared to the consensus revenue estimate of $957.61 million. Sensata Technologies also updated its Q4 2024 guidance to 0.710-0.760 EPS.
Sensata Technologies Stock Down 2.4 %
ST traded down $0.84 on Monday, hitting $33.64. 2,346,150 shares of the company were exchanged, compared to its average volume of 1,860,234. Sensata Technologies has a twelve month low of $30.56 and a twelve month high of $43.14. The company has a market cap of $5.08 billion, a price-to-earnings ratio of 841.00, a price-to-earnings-growth ratio of 1.36 and a beta of 1.25. The company has a current ratio of 1.77, a quick ratio of 1.31 and a debt-to-equity ratio of 1.06. The firm has a 50-day moving average price of $35.75 and a two-hundred day moving average price of $37.70.
Sensata Technologies Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Wednesday, November 27th. Investors of record on Wednesday, November 13th will be paid a dividend of $0.12 per share. The ex-dividend date is Wednesday, November 13th. This represents a $0.48 annualized dividend and a yield of 1.43%. Sensata Technologies’s payout ratio is 1,200.00%.
Wall Street Analyst Weigh In
Sensata Technologies Company Profile
Sensata Technologies Holding plc develops, manufactures, and sells sensors and sensor-rich solutions, electrical protection components and systems, and other products used in mission-critical systems and applications in the United States and internationally. It operates in two segments, Performance Sensing and Sensing Solutions.
Featured Articles
- Five stocks we like better than Sensata Technologies
- How to Invest in Small Cap Stocks
- Intel: Is Now the Time to Be Brave?
- What Are Dividend Achievers? An Introduction
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- Where to Find Earnings Call Transcripts
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Sensata Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sensata Technologies and related companies with MarketBeat.com's FREE daily email newsletter.